First-line pembrolizumab for metastatic non-small-cell lung cancer

Article Properties
  • DOI (url)
    10.36290/xon.2020.086
  • Publication Date
    2020/11/19
  • Journal
    Onkologie
  • Indian UGC (journal)
  • Refrences
    2
  • Markéta Černovská
  • Marie Drösslerová
Cite
Černovská, Markéta, and Marie Drösslerová. “First-Line Pembrolizumab for Metastatic Non-Small-Cell Lung Cancer”. Onkologie, vol. 14, no. Suppl.F, 2020, pp. 154-5, https://doi.org/10.36290/xon.2020.086.
Černovská, M., & Drösslerová, M. (2020). First-line pembrolizumab for metastatic non-small-cell lung cancer. Onkologie, 14(Suppl.F), 154-155. https://doi.org/10.36290/xon.2020.086
Černovská M, Drösslerová M. First-line pembrolizumab for metastatic non-small-cell lung cancer. Onkologie. 2020;14(Suppl.F):154-5.
Refrences
Title Journal Journal Categories Citations Publication Date
10.1200/JCO.18.00149
10.1056/NEJMoa1606774